EUVIMEDEUVIMED entdecken
Crossref

Pediatric Invasive Pneumococcal Disease Spectrum Before Third-Generation Pneumococcal Conjugate Vaccine Implementation

Corinne Levy iD, Aude Estivaux, Emmanuelle Varon iD, Stéphane Béchet, Naim Ouldali, Isabelle Hau, Robert Cohen

Journal of the Pediatric Infectious Diseases Society · 2025

DOI: 10.1093/jpids/piaf056 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Pediatric Infectious Diseases Society, 2025. Verfasst von Corinne Levy und 6 weiteren Autor:innen. Beteiligte Einrichtung: ACTIV, Association Clinique et Thérapeutique Infantile du Val-de-Marne, 94000 Créteil, France. Hauptthemen laut MEDLINE: Pneumococcal Vaccines, Pneumococcal Infections, Streptococcus pneumoniae. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: PFIZER.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

After the implementation of pneumococcal conjugate vaccines (PCVs), besides the decrease of invasive pneumococcal disease (IPD), the clinical spectrum of the remaining cases changed, with many differences among serotypes. This study aimed to describe the clinical profile of IPD and the serotype distribution 15 years after PCV13 implementation and before the implementation of third-generation PCVs.

Methods

From 2017 to 2022, 128 French pediatric wards prospectively reported IPDs in children. Data were collected on demographics and clinical data, underlying conditions increasing the risk of IPD and outcome. Four clinical entities were considered: meningitis, bacteremia without source, bacteremic pneumonia, and other IPD.

Results

Among 931 IPD cases (median age of children: 19.2 months, Interquartile range (IQR): 7.7-52.5), meningitis accounted for 36.4%, followed by bacteremia without source (31.6%), bacteremic pneumonia (20.5%), and other IPDs (11.5%). Underlying conditions were reported in 21.5% of children. Death was reported in 4.8% of IPD cases and meningitis represented 51.1% of fatal cases. PCV13 serotypes, mainly 3, 19A, and 19F, still accounted for 15.0% of cases. PCV15 covered 6.2% more serotypes than did PCV13, whereas PCV20 covered 29.1% more serotypes than did PCV15. PCV20 non-PCV13 and PCV13 serotypes accounted for 33.3% and 11.1% of deaths, respectively. Serotype 24F ranked first and accounted for 16.4% of overall IPD cases.

Conclusions

From 2017 to 2022, among 931 IPD cases, PCV20 non-PCV13 serotypes (35.0% of cases) were implicated in 33.3% of deaths. Serotype 24F ranked first in overall IPD cases but is not included in third-generation PCVs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pneumococcal VaccinesPneumococcal InfectionsStreptococcus pneumoniaeHumansInfantChild, PreschoolMaleFemaleFranceSerogroupBacteremiaChildVaccines, ConjugateProspective StudiesMeningitis, Pneumococcal

Stichwörter der Autor:innen

childreninvasive pneumococcal diseasepneumococcal conjugate vaccineserotypeunderlying conditions

Substanzen

Pneumococcal VaccinesVaccines, Conjugate13-valent pneumococcal vaccine

Autor:innen und Institutionen

  • ACTIV, Association Clinique et Thérapeutique Infantile du Val-de-Marne, 94000 Créteil, France.
  • AFPA, Association Française de Pédiatrie Ambulatoire, 30400 Villeneuve les Avignons, France.
  • GPIP, Groupe de Pathologie Infectieuse Pédiatrique, 75000 Paris, France.
  • Université Paris Est, IMRB-GRC GEMINI, 94000 Créteil, France.
  • Clinical Research Center (CRC), Centre Hospitalier Intercommunal de Créteil, 94000 Créteil, France.
  • Service de pédiatrie Hôpital de Villeneuve Saint Georges, 94190 Villeneuve Saint Georges, France.

ORCID-Profile: Corinne Levy, Emmanuelle Varon

Förderung

  • PFIZER

Zitieren

APA

Levy, C., Estivaux, A., Varon, E., Béchet, S., Ouldali, N., Hau, I., & Cohen, R. (2025). Pediatric Invasive Pneumococcal Disease Spectrum Before Third-Generation Pneumococcal Conjugate Vaccine Implementation. Journal of the Pediatric Infectious Diseases Society. https://doi.org/10.1093/jpids/piaf056

Vancouver

Levy C, Estivaux A, Varon E, Béchet S, Ouldali N, Hau I, et al. Pediatric Invasive Pneumococcal Disease Spectrum Before Third-Generation Pneumococcal Conjugate Vaccine Implementation. Journal of the Pediatric Infectious Diseases Society. 2025. doi:10.1093/jpids/piaf056

BibTeX
@article{Levy2025,
  author = {Levy, Corinne and Estivaux, Aude and Varon, Emmanuelle and Béchet, Stéphane and Ouldali, Naim and Hau, Isabelle and Cohen, Robert},
  title = {Pediatric Invasive Pneumococcal Disease Spectrum Before Third-Generation Pneumococcal Conjugate Vaccine Implementation},
  journal = {Journal of the Pediatric Infectious Diseases Society},
  year = {2025},
  doi = {10.1093/jpids/piaf056}
}
Kostenlos starten →